1. Home
  2. SCLX vs NTZ Comparison

SCLX vs NTZ Comparison

Compare SCLX & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • NTZ
  • Stock Information
  • Founded
  • SCLX 2011
  • NTZ 1959
  • Country
  • SCLX United States
  • NTZ Italy
  • Employees
  • SCLX N/A
  • NTZ N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • SCLX Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • SCLX Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • SCLX 35.7M
  • NTZ 31.2M
  • IPO Year
  • SCLX N/A
  • NTZ 1993
  • Fundamental
  • Price
  • SCLX $18.87
  • NTZ $3.11
  • Analyst Decision
  • SCLX Strong Buy
  • NTZ
  • Analyst Count
  • SCLX 3
  • NTZ 0
  • Target Price
  • SCLX $367.50
  • NTZ N/A
  • AVG Volume (30 Days)
  • SCLX 324.6K
  • NTZ 8.0K
  • Earning Date
  • SCLX 08-13-2025
  • NTZ 07-02-2025
  • Dividend Yield
  • SCLX N/A
  • NTZ N/A
  • EPS Growth
  • SCLX N/A
  • NTZ N/A
  • EPS
  • SCLX N/A
  • NTZ N/A
  • Revenue
  • SCLX $44,236,000.00
  • NTZ $337,653,480.00
  • Revenue This Year
  • SCLX $89.26
  • NTZ N/A
  • Revenue Next Year
  • SCLX $203.95
  • NTZ N/A
  • P/E Ratio
  • SCLX N/A
  • NTZ N/A
  • Revenue Growth
  • SCLX N/A
  • NTZ N/A
  • 52 Week Low
  • SCLX $3.60
  • NTZ $2.15
  • 52 Week High
  • SCLX $45.15
  • NTZ $6.27
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 63.34
  • NTZ 59.66
  • Support Level
  • SCLX $15.61
  • NTZ $2.70
  • Resistance Level
  • SCLX $22.01
  • NTZ $3.24
  • Average True Range (ATR)
  • SCLX 2.21
  • NTZ 0.24
  • MACD
  • SCLX -0.14
  • NTZ 0.05
  • Stochastic Oscillator
  • SCLX 62.35
  • NTZ 76.92

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

Share on Social Networks: